MIMEDX – AMNIOFIX

AMNIOFIX^® is a tissue allograft composed of dehydrated human amnion/chorion membrane (DHACM). It is available in sheet, fenestrated, and wrap configurations in a variety of sizes to reduce wastage.

Protective Environment

AMNIOFIX provides a protective barrier that supports the healing cascade and protects the wound bed to aid in the development of granulation tissue in acute and chronic closures.

Regulatory Proteins

AMNIOFIX provides a biocompatible human extracellular matrix and contains 300+ regulatory proteins.1-3

Request a demo, quote or ask a question.

Product Advantages

Human-derived
Multiple configurations available for varying demands depending on wound or surgical application desired
Provides a human biocompatible extracellular matrix
Simple storage and application
Compatible with negative pressure wound therapy (NPWT) and hyperbaric oxygen therapy (HBOT)

Clinical Use Examples

AMNIOFIX has been used across a wide range of surgical applications including:

Debridement
Surgical wounds
Dehiscence repair
Tendon & ligament repair
Myomectomies
Bunionectomies
Rotator cuff repair
Posterior Lumbar Interbody Fusion (PLIF)
Total knee & shoulder arthroplasty
Limb salvage
Amputations
Pilonidal cysts
Port sites
Other cases are possible

AMNIOFIX Processing & Details

AMNIOFIX is processed using PURION, a unique patented method for placental-based allografts that is in accordance with the American Association of Tissue Banks (AATB) standards. The product is derived from placental tissue donated by healthy, consenting mothers who have given live Caesarean section birth in the US.

MIMEDX’s patented PURION process preserves extracellular matrix components, including regulatory factors and other matrix-associated proteins. For an additional level of safety, the product is terminally sterilized.

Koob TJ, Lim JJ, Massee M, Zabek N, Denozière G. Properties of dehydrated human amnion/chorion composite grafts: Implications for wound repair and soft tissue regeneration. J Biomed Mater Res B Appl Biomater. 2014;102(6):1353-1362.
Lei J, Priddy LB, Lim JJ, Massee M, Koob TJ. Identification of Extracellular Matrix Components and Biological Factors in Micronized Dehydrated Human Amnion/Chorion Membrane. Adv Wound Care (New Rochelle). 2017;6(2):43-53.
MIMEDX Internal Report. MM-RD-00086, Proteome Characterization of PURION Processed Dehydrated Human Amnion Chorion Membrane (dHACM) and PURION PLUS Processed Dehydrated Human Umbilical Cord (dHUC) Allografts.